Open AccessTwo-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy
Author(s) -
Masahiro Miura,
Nemoto,
Iwasaki,
Goto
Publication year - 2012
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s37252
Subject(s) - medicine , photodynamic therapy , visual acuity , ophthalmology , ranibizumab , retinal , regimen , indocyanine green angiography , fluorescein angiography , surgery , chemotherapy , bevacizumab , chemistry , organic chemistry
We evaluated the 2-year efficacy of combined intravitreal ranibizumab (IVR) treatment and photodynamic therapy (PDT) for treatment-naïve polypoidal choroidal vasculopathy (PCV).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom